Recent News

• 10.20.2025 - Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors
• 10.20.2025 - Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors
• 09.23.2025 - Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025
• 09.23.2025 - Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.05.2025 - H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
• 09.03.2025 - Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
• 08.05.2025 - Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• 08.05.2025 - Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Recent Filings

• 08.05.2025 - 8-K Current report
• 08.05.2025 - EX-99.1 EX-99.1
• 08.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.09.2025 - 8-K Current report
• 06.13.2025 - 8-K Current report
• 05.23.2025 - 4 Statement of changes in beneficial ownership of securities